Monday, September 27, 2021

FOX NEWS: Pfizer begins Phase 2/3 study for COVID-19 oral antiviral in exposed adults


Pfizer begins Phase 2/3 study for COVID-19 oral antiviral in exposed adults



Pfizer initiated a Phase 2/3 study of an investigational oral antiviral with a low dose of ritonavir to prevent COVID-19 illness, the company announced Monday.

via FOX NEWS https://ift.tt/3CT9zrd
Posted by at
Labels: ,

No comments:

Post a Comment

Thanks for your comment reply within 24 hours

Subscribe to: Post Comments (Atom)